Ikarian Capital, LLC Options Holdings

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
XBI
Spdr Ser Tr Spdr S&P Biotech E

ETFs
PUT
$49.4 Million
500K
Q3 2024
New holding
AMGN
Amgen Inc

Healthcare
CALL
$47 Million
146K
Q3 2024
Added 24233.33%
VRTX
Vertex Pharmaceuticals Inc

Healthcare
CALL
$46.5 Million
100K
Q3 2024
New holding
VRTX
Vertex Pharmaceuticals Inc

Healthcare
PUT
$46.5 Million
100K
Q3 2024
New holding
JANX
Janux Therapeutics, Inc.

Healthcare
PUT
$16.6 Million
365K
Q3 2024
New holding
IMVT
Immunovant, Inc.

Healthcare
CALL
$13.8 Million
500K
Q3 2024
Added 49900.0%
CLDX
Celldex Therapeutics, Inc.

Healthcare
PUT
$10.4 Million
306K
Q3 2024
New holding
CLDX
Celldex Therapeutics, Inc.

Healthcare
CALL
$10.4 Million
306K
Q3 2024
New holding
BGNE
Bei Gene, Ltd.

Healthcare
CALL
$6.69 Million
29.8K
Q3 2024
New holding
APLS
Apellis Pharmaceuticals, Inc.

Healthcare
PUT
$5.77 Million
200K
Q3 2024
New holding
MDGL
Madrigal Pharmaceuticals, Inc.

Healthcare
PUT
$4.99 Million
23.5K
Q3 2024
New holding
DYN
Dyne Therapeutics, Inc.

Healthcare
PUT
$4.78 Million
133K
Q3 2024
New holding
CAPR
Capricor Therapeutics, Inc.

Healthcare
PUT
$4.56 Million
300K
Q3 2024
New holding
CAPR
Capricor Therapeutics, Inc.

Healthcare
CALL
$4.56 Million
300K
Q3 2024
New holding
VRDN
Viridian Therapeutics, Inc.\De

Healthcare
CALL
$4.55 Million
200K
Q3 2024
Added 19900.0%
APLS
Apellis Pharmaceuticals, Inc.

Healthcare
CALL
$4.33 Million
150K
Q3 2024
New holding
BDTX
Black Diamond Therapeutics, Inc.

Healthcare
PUT
$4.13 Million
950K
Q3 2024
New holding
BDTX
Black Diamond Therapeutics, Inc.

Healthcare
CALL
$3.04 Million
700K
Q3 2024
New holding
CYTK
Cytokinetics Inc

Healthcare
CALL
$2.76 Million
52.3K
Q3 2024
New holding
SANA
Sana Biotechnology, Inc.

Healthcare
CALL
$2.7 Million
650K
Q3 2024
Added 16150.0%
SANA
Sana Biotechnology, Inc.

Healthcare
PUT
$2.7 Million
650K
Q3 2024
Added 16150.0%
RCUS
Arcus Biosciences, Inc.

Healthcare
CALL
$1.74 Million
114K
Q3 2024
New holding
SRRK
Scholar Rock Holding Corp

Healthcare
CALL
$1.62 Million
202K
Q3 2024
New holding
SRRK
Scholar Rock Holding Corp

Healthcare
PUT
$1.62 Million
202K
Q3 2024
New holding
FULC
Fulcrum Therapeutics, Inc.

Healthcare
CALL
$1.51 Million
423K
Q3 2024
New holding
SWTX
Spring Works Therapeutics, Inc.

Healthcare
CALL
$1.4 Million
43.8K
Q3 2024
New holding
GALT
Galectin Therapeutics Inc

Healthcare
PUT
$1.38 Million
500K
Q3 2024
New holding
GALT
Galectin Therapeutics Inc

Healthcare
CALL
$1.38 Million
500K
Q3 2024
New holding
PYXS
Pyxis Oncology, Inc.

Healthcare
CALL
$1.32 Million
359K
Q3 2024
Added 9900.0%
CRVS
Corvus Pharmaceuticals, Inc.

Healthcare
CALL
$1.15 Million
218K
Q3 2024
New holding
BMEA
Biomea Fusion, Inc.

Healthcare
PUT
$535,000
53K
Q3 2024
New holding
PRTA
Prothena Corp Public LTD CO

Healthcare
CALL
$197,000
11.8K
Q3 2024
New holding
PRTA
Prothena Corp Public LTD CO

Healthcare
PUT
$197,000
11.8K
Q3 2024
New holding
FULC
Fulcrum Therapeutics, Inc.

Healthcare
PUT
$81,000
22.8K
Q3 2024
New holding
Perspective Therapeutics Inc
PUT
$0
77.1K
Q3 2024
New holding
Alto Neuroscience Inc
PUT
$0
450K
Q3 2024
New holding
Alto Neuroscience Inc
CALL
$0
431K
Q3 2024
New holding
Biohaven LTD
PUT
$0
326K
Q3 2024
New holding
Anaptysbio Inc
PUT
$0
404K
Q3 2024
New holding
Solid Biosciences Inc
CALL
$0
300K
Q3 2024
New holding
Corbus Pharmaceuticals Hldgs
PUT
$0
233K
Q3 2024
New holding
Corbus Pharmaceuticals Hldgs
CALL
$0
108K
Q3 2024
New holding
Apogee Therapeutics Inc
CALL
$0
5K
Q3 2024
New holding
Anaptysbio Inc
CALL
$0
350K
Q3 2024
New holding
Neumora Therapeutics Inc.
PUT
$0
400K
Q3 2024
New holding
Neumora Therapeutics Inc.
CALL
$0
400K
Q3 2024
New holding
NAMS
Newamsterdam Pharma CO Nv Shs
CALL
$0
29.1K
Q3 2024
New holding
Soleno Therapeutics Inc
CALL
$0
110K
Q3 2024
New holding

Summary

  • Portfolio
  • No. of Stocks 145
  • Current Value $573 Million
  • Prior Value $247 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 21 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 28 stocks
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email